Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

235.84 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Why Catalent Stock Tumbled by Nearly 6% on Tuesday
A warning about revenue and the abandonment of a potential suitor are recent developments that continue to hammer sentiment on the company. 
Via The Motley Fool
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
These 2 Large-Cap Laggards Are Leading Markets Lower Tuesday
Investors worry that an economic recession could hit entire swaths of the stock market hard. 
Via The Motley Fool
Why Danaher Shares Are Falling Today
Via Benzinga
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
Looking At Danaher's Recent Unusual Options Activity
Via Benzinga
Here's How Much $100 Invested In Danaher 5 Years Ago Would Be Worth Today
Via Benzinga
Why Catalent Shares Are Falling Today
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Catalent Stock Dove More Than 7% Today
The specialty healthcare company is having a miserable couple of days on the exchange. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
Why Catalent Stock Slumped on Monday
It looks like the company won't be acquired after all...at least for now. 
Via The Motley Fool
What 5 Analyst Ratings Have To Say About Danaher
Via Benzinga
7 Stocks That Hedge Funds Are Dumping Now
Everyone loves talking about what institutional players are buying. On the flipside, here’s a list of hedge fund stocks to avoid. 
Via InvestorPlace
3 Stocks to Buy for Life-Changing Wealth Potential
Investors hoping to succeed in the stock market should consider taking a position in these leading companies, each of which has outperformed. 
Via InvestorPlace
Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
B of A Securities cut the price target for Stem, Inc. (NYSE: STEM) from $9 to $5. B of A Securities analyst Julien Dumoulin-Smith downgraded the stock from Neutral to Underperform. Stem shares fell... 
Via Benzinga
$100 Invested In Danaher 5 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Via Benzinga
Looking At Danaher's Recent Unusual Options Activity
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Via Benzinga
Here's How Much $1000 Invested In Danaher 5 Years Ago Would Be Worth Today
Via Benzinga
Eli Lilly Stock Shows Improved Relative Price Performance; Still Shy Of Benchmark
On Tuesday, Eli Lilly stock got an upgrade to its Relative Strength (RS) Rating, to 74 from 68 a day earlier. 
Via Investor's Business Daily
This Year’s 5 Top InvestorPlace.com Stock Pickers
If you are looking for stocks to buy, the top InvestorPlace.com stock pickers have demonstrated their skills so far in 2023. 
Via InvestorPlace
The 7 Most Undervalued Stocks to Buy in March 2023
These most undervalued stocks to buy are trading at hefty bargains offering tremendous upside potential ahead in the not-so-distant future 
Via InvestorPlace
EXCLUSIVE: Benzinga's Favorite Hedge Funds To Watch During 13F Season
It’s hedge fund season. Hedge funds with more than $100 million in assets are required to file a Form 13F with the U.S. Securities and Exchange Commission (SEC) within 45 days of the end of each... 
Via Benzinga
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
All three companies have shown consistent revenue and EPS growth. 
Via The Motley Fool
3 Large-Cap Biotech Stocks to Hold for the Long Haul
These three large-cap biotech stocks survived or went up in 2022 when most of the market went down by double digits. 
Via InvestorPlace
7 Stocks to Buy for the Future of Clean Water Technology
Here are seven clean water stocks that are using clean water technology to address the growing issue of water scarcity. 
Via InvestorPlace
7 Hot Healthcare Stocks With the Potential to Outperform
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.